Cite

HARVARD Citation

    Cruz, C. et al. (2018). RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer. Annals of oncology. pp. 1203-1210. [Online]. 
  
Back to record